Photodynamic treatment with verteporfin for patients with idiopathic choroidal neovascularization. Two-year results;Photodynamische therapie mit verteporfin bei patienten mit idiopathischer chorioidaler neovaskularisation: 2-Jahres-ergebnisse

Ophthalmologe

Volumn 101, Issue 5, 2004, Pages 489-495

  Wachtlin, J ^a   Wehner, A ^a   Heimann, H ^a   Foerster, M H ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Age related macular degeneration; Exudative maculopathy; Idiopathic choroidal neovascularization; Photodynamic therapy

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; PHOTOSENSITIZING AGENT; PORPHYRIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; MALE; PHOTODYNAMIC THERAPY; RETINA FOVEA; RETROSPECTIVE STUDY; SUBRETINAL NEOVASCULARIZATION; ADOLESCENT; DRUG EFFECT; EVALUATION; METHODOLOGY; MIDDLE AGED; PHOTOCHEMOTHERAPY; PIGMENT EPITHELIUM; RECURRENT DISEASE; TREATMENT OUTCOME; VISUAL ACUITY;

ADOLESCENT; ADULT; CHOROIDAL NEOVASCULARIZATION; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PIGMENT EPITHELIUM OF EYE; PORPHYRINS; RECURRENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 3142751088     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00347-004-0993-5     Document Type: Article

References (20)

1. Behrens-Baumann W, Ecker S, Vogel M, Ritter K (1988) Das sog. okuläre Histoplasmose-Syndrom. Klin Monatsbl Augenheilkd 192:348-353
2. Blinder KJ, Blumenkranz MS, Bressler NM et al. (2003) Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial -VIP report no. 3. Ophthalmology 110:667-673
3. Bressler NM (2001) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials - tap report 2. Arch Ophthalmol 119:198-207
4. Cleasby GW (1976) Idiopathic focal subretinal neovascularization. Am J Ophthalmol 81:590-599
5. Cohen SY, Laroche A, Leguen Y, Soubrane G, Coscas GJ (1996) Etiology of choroidal neovascularization in young patients. Ophthalmology 103:1241-1244
6. Karacorlu M, Karacorlu S, Ozdemir H, Mat C (2002) Photodynamic therapy with verteporfin for choroidal neovascularization in patients with angioid streaks. Am J Ophthalmol 134:360-366
7. Lindblom B, Andersson T (1998) The prognosis of idiopathic choroidal neovascularization in persons younger than 50 years of age. Ophthalmology 105:1816-1820
8. Macular Photocoagulation Study Group (1986) Recurrent choroidal neovascularization after argon laser photocoagulation for neovascularmaculopathy. Arch Ophthalmol 104:503-512
9. Macular Photocoagulation Study Group (1990) Krypton laser photocoagulation for idiopathic neovascular lesions. Results of a randomized clinical trial. Arch Ophthalmol 108:832-837
10. Macular Photocoagulation Study Group (1994) Laser photocoagulation for juxtafoveal choroidal neovascularization. Five-year results from randomized clinical trials. Arch Ophthalmol 112:500-509
11. Macular Photocoagulation Study Group (1995) Laser photocoagulation for neovascular lesions nasal to the fovea. Results from clinical trials for lesions secondary to ocular histoplasmosis or idiopathic causes. Arch Ophthalmol 113:56-61
12. Müller-Veiten R, Michels S, Schmidt-Erfurth U, Laqua H (2003) Photodynamische Therapie: Erweiterte Indikationen. Ophthalmologe 100:384-390
13. Saperstein DA, Rosenfeld PJ, Bressler NM et al. (2002) Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome: one-year results of an uncontrolled, prospective case series. Ophthalmology 109:1499-1505
14. Shaikh S, Ruby AJ,Williams GA (2003) Photodynamic therapy using verteporfin for choroidal neovascularization in angioid streaks. Am J Ophthalmol 135:1-6
15. Sickenberg M, Schmidt-Erfurth U, Miller JW et al. (2000) A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes. Arch Ophthalmol 118:327-336
16. Spaide RF, Martin ML, Slakter J et al. (2002) Treatment of idiopathic subfoveal choroidal neovascular lesions using photodynamic therapy with verteporfin. Am J Ophthalmol 134:62-68
17. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group (1999) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials - TAP report. Arch Ophthalmol 117:1329-1345
18. Verteporfin in Photodynamic Therapy (VIP) Study Group (2001) Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial - VIP report no. 1. Ophthalmology 108:841-852
19. Wachtlin J, BehmeT, Heimann H, Kellner U, Foerster MH (2003) Concentric retinal pigment epithelium atrophy after a single photodynamic therapy. Graefes Arch Clin Exp Ophthalmol 241:518-521
20. Wachtlin J, Heimann H, BehmeT, Foerster MH (2003) Long-term results after photodynamic therapy (PDT) with Verteporfin for choroidal neovascularisation (CNV) secondary to inflammatory chorioretinal diseases. Graefes Arch Clin Exp Ophthalmol 241:899-906